Discovering Dendritic Cell Therapy
Dendritic cell based immunotherapy was first approved in 2010 in the United States as a vaccination cancer therapy for prostate cancer and cancer cell treatment. Since then, there have been over 4,500 studies during clinical trials published on patients treated with this cancer vaccine. In cancer research studies, dendritic cell cancer treatment has been found to provide therapeutic and protective antitumor immunities. Clinical trials for cancer patients with melanoma, glioma, and non-Hodgkin’s lymphoma show promising antitumor results. Dendritic cell therapy is also proven to be effective in providing an immune cell response for pancreatic cancer, lung cancer, and breast cancer during clinical trials.
How Does Dendritic Cell Therapy & Vaccine Treatment Work
Dendritic cell (DC) cancer cell vaccine treatment is a unique form of immunotherapy that has become more relevant among cancer patients. Autologous dendritic cells are rare leukocytes, a type of cell that plays a role in signaling the body’s immune system and developing stem cells in the bone marrow. The Dendritic cell is the most potent type of antigen presenting cell that is vital to proliferate T-lymphocyte, also known as a T Cell. Antigen helps the body trigger an immune response. By activating T cells with dc vaccination, dendritic cells help to promote antitumor immunity . These immune cells can help prevent the onset of cancer by suppressing tumor cell growth rates.
Dendritic cell therapy works by isolating dendritic cells with tumor antigen-loaded mature dendritic cells and administering them as a cellular, therapeutic vaccine. The process of performing DC therapy includes:
- Simple blood draw.
- Filtering of monocyte cells from peripheral blood and then loading it with tumor-associated antigens (TAA).
- Dendritic cell vaccination is then administered to the patient to attack tumour cells by activating T Cells in the lymph node(s).
Administrating DC therapy in a combination therapy with conventional cancer treatments such as chemotherapy and radiotherapy can serve as a promising treatment plan to improve its efficacy as well as boost the performance of the immune system.
How Is Dendritic Cell Therapy Administered?
Dendritic therapy via the dendritic cell vaccine can be injected intravenously, intramuscularly, intradermally, or directly into the tumor. Intervals for injection frequency of the DC vaccine can range from days to months to adapt an immune response. Consult with your doctor to determine the best mode of administration, dosage, and frequency of cancer immunotherapy based on your personal health needs.
Additional Questions? Call Immunity Therapy Center today and get started on your path towards recovery!
- “Optimizing Dendritic Cell-Based Approaches for Cancer Immunotherapy” ( Datta, Jashodeep; Terhune, Julia H.; Lowenfeld, Lea; Cintolo, Jessica A.; Xu, Shuwen; Roses, Robert E.; Czerniecki, Brian J.) : https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4257036/
- “ISOLATION AND GENERATION OF HUMAN DENDRITIC CELLS” by Smita Nair, Thomas Tedder, Gerald E. Archer: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4559332/
- “Manufacturing Dendritic Cells for Immunotherapy: Monocyte” by : https://www.cell.com/molecular-therapy-family/methods/fulltext/S2329-0501(20)30008-5
At Immunity Therapy Center, our goal is to provide objective, updated, and research-based information on all health-related topics. This article is based on scientific research and/or other scientific articles. All information has been fact-checked and reviewed by Dr. Carlos Bautista, a Board Certified Medical Doctor at Immunity Therapy Center. All information published on the site must undergo an extensive review process to ensure accuracy. This article contains trusted sources with all references hyperlinked for the reader's visibility.
Customized Care For the Body And The Mind
Discuss Your Custom Alternative Treatment Plan With Our Team Today
Hear from Our Patients
See why the Immunity Therapy Center is a trusted name for medical tourism and cancer treatment centers in Mexico.
Karla Leonard, from Riverside, CA, battled Stage IV metastatic breast cancer with unwavering determination. Despite her initial disbelief at her deteriorating health, she found hope in ITC. Choosing ITC for treatment in May 2013, Karla harbored high hopes. She pressed on despite her son’s reservations. From day one, ITC impressed her with excellent service and […]
Hailing from Calgary, Canada, Sadie Litosky’s life took a turn when she was diagnosed with Stage 4 Hodgkin’s Lymphoma at just 19 years old. In a few short months, this first-year university student went from having a minor neck lump to facing breathing difficulties and chest pains. Sadie’s mother tirelessly researched treatment options worldwide and […]
Facing Stage III Hodgkin’s Lymphoma, Gabrielle Friscia and her family sought comprehensive treatment within their country’s borders. Unfortunately, their search came up short. By chance, it was Gabrielle’s father who discovered the ITC just days after her diagnosis. Initially skeptical about pursuing treatment in Mexico, like any patient, they embarked on this medical journey. The […]
Troy Clark was diagnosed with Stage 3 Prostate Cancer back in 2018. After watching his father go through chemo and radiation therapy on three different occasions, Troy wanted to explore other options. Through a referral of a friend, he found Immunity Therapy Center. “Everyone at ITC treats me with the utmost respect. What I get […]
“The Immunity Therapy Center Saved My Life and I Hope they Can Help You Too” On March 14th Debbie was diagnosed with a rare type of Ampullary and Liver Cancer. Her doctors told her that her diagnosis was essentially a death sentence. After some extensive research, Debbie discovered ITC online and decided it was worth […]
Martin Ocegueda is a resident of Temecula, California. In 2022, he arrived at ITC and was diagnosed with Stage 4 Pancreatic Cancer. After being told by prior doctors that he only had 3 months to live, Ocegueda knew he needed to seek alternative treatment. His mother referred him to ITC, as his sister received treatment […]
9 years ago Clara Kornelsen came to ITC for treatment after being diagnosed with Breast Cancer. Although she was living in Canada at the time and healthcare was free, she felt it was the right thing to come to ITC for treatment. Today, Clara is “strong and healthy as ever” and thanks Dr. Bautista for […]
Arthur Rivas, a California resident and Master of Science and Nursing, was diagnosed with Stage 3A Non-Small Cell Lung Cancer. Arthur, who has spent most of his life caring for others through the field of nursing, never thought he would be the one requiring extensive medical attention. With so much knowledge in the medical field, […]
Peter Richardson was having significantly increasing pain in his stomach earlier in February. Following doctors orders for treating constipation, Peter took laxatives and pain killers for 5 months, but nothing was helping. When he went back to the doctor a second time they did a CT scan and found a large mass in his abdomen […]
Prior to being diagnosed with Hodgkin Lymphoma, Melissa Porter lead a very healthy lifestyle. While traveling in Costa Rica she found a lump in her right underarm that was found to be Cancerous. When Melissa returned home she researched a variety of alternative treatment options and after being told about Immunity Therapy Center by her […]